Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Trials|January 19, 2021
Diabetes management intervention studies: lessons learned from two studiesBettina Petersen, Iris Vesper, Bernhild Pachwald, et al.Journal of Diabetes Science and Technology|August 6, 2019
Benefit of Digital Tools Used for Integrated Personalized Diabetes Management: Results From the PDM-ProValue Study ProgramLutz Heinemann, Wendelin Schramm, Helena Koenig, et al.Diabetes Research and Clinical Practice|September 12, 2018
Integrated personalized diabetes management improves glycemic control in patients with insulin-treated type 2 diabetes: Results of the PDM-ProValue study programBernhard Kulzer, Wilfried Daenschel, Ingrid Daenschel, et al.Journal of Diabetes Science and Technology|March 8, 2024
A Three-Arm Randomized Controlled Study Comparing Patient-Reported Outcomes in People With Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion or Multiple Daily InjectionsKatharine Barnard-Kelly, Florian Thienel, Julia K Mader, et al.BMC Family Practice|October 16, 2012
Automated bolus advisor control and usability study (ABACUS): does use of an insulin bolus advisor improve glycaemic control in patients failing multiple daily insulin injection (MDI) therapy? [NCT01460446]David A Cavan, Ralph Ziegler, Iain Cranston, et al.Journal of Diabetes Science and Technology|December 10, 2015
Integrated Personalized Diabetes Management (PDM): Design of the ProValue Studies: Prospective, Cluster-Randomized, Controlled, Intervention Trials for Evaluation of the Effectiveness and Benefit of PDM in Patients With Insulin-Treated Type 2 DiabetesBernhard Kulzer, Wilfried Daenschel, Ingrid Daenschel, et al.Diabetes Care|August 1, 2013
Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trialRalph Ziegler, David A Cavan, Iain Cranston, et al.Diabetes Technology & Therapeutics|April 11, 2014
Use of an insulin bolus advisor facilitates earlier and more frequent changes in insulin therapy parameters in suboptimally controlled patients with diabetes treated with multiple daily insulin injection therapy: results of the ABACUS trialDavid A Cavan, Ralph Ziegler, Iain Cranston, et al.Journal of Clinical & Translational Endocrinology|November 22, 2017
Use of an integrated strip-free blood glucose monitoring system increases frequency of self-monitoring and improves glycemic control: Results from the ExAct studyAlberto Maran, Diethelm Tschoepe, Maurizio Di Mauro, et al.Pageof 1